(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

POWERED BY BIOHM

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

POWERED BY BIOHM

ST13

US500000087757230

Class

1, 5

Filing

87757230

Registration

6707595

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

53

Latest update

10/26/2025

Trademark type

Word

Nice classes

1, 5

Filing date

01/16/2018

Registration date

04/19/2022

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

04/19/2022

Last transaction

10/26/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

02/17/2022

First use in commerce

02/17/2022

Drawing code

4

Owner type

99

Owner location

CLEVELAND, OH

Examiner

SMITH,CYNTHIA RINALDI

Law office

L70

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

BIOHM HEALTH INC.
BIOHM HEALTH LLC
PathoBiome LLC

Representatives

Lisa C. Pavento Meunier Carlin & Curfman LLC

Technical classification

Nice Classes

Class 1Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

Food products containing probiotic compositionsprobiotic bacteria and probiotic bacterial cultures for use as a food additive for food manufacturing; human food products containing probiotic compositionsprobiotic bacteria and probiotic bacterial cultures for use as a food additive for food manufacturing; animal food products containing probiotic compositionsnutritional additives for use in manufacturing animal feed

Class 5

Probiotic supplements; vitamin and mineral supplements; vitamin supplements; whey protein supplements; dietary supplement drink mixes; dietary supplement for eliminating toxins from the intestinal tract; enzyme food supplements; herbal supplements; mineral supplements; multi-vitamin preparations; natural herbal supplements; nutraceuticals for use as a dietary supplement; nutritional supplement for eliminating toxins from the intestinal tract; nutritional supplement shakes; nutritional supplementsprobiotic compositions; nutritional supplementscarbohydrates in powdered form; powdered nutritional supplement concentrate; vitamin and mineral supplements in powdertabletliquidcapsule or spray form; mineral supplements in powdertabletliquidcapsule or spray form; dietary supplements in powdertabletliquidcapsule or spray form; food supplements providing a source of vitamins and minerals and essential fatty acids and probiotic cultures in powdertabletliquidcapsule or spray form; nutritional supplements for human consumption providing a source of vitamins and minerals and essential fatty acids and probiotic cultures in powdertabletliquidcapsule or spray form; herbal supplements for general health and well-beingin powdertabletliquidcapsule or spray form; nutritional supplementsprobiotic compositions in the nature of a vaginal probiotic for the treatment and prevention of bacterial and fungal vaginal infection; nutraceuticals for the treatment and prevention of bacterial vaginosisvaginal discharge and odorsfor preventing the growth of undesirable micro-organisms that can cause vaginal discharge and odorkilling bacteria that cause bacterial vaginosisfor maintaining a desirable microflora in the vaginal cavity; micro-organisms culture for medical uselactic acid bacteria and bifidobacteria having probiotic activity on humans for the treatment of diseasesintestinal disordersdiarrhea and to re-equilibrate the intestinal bacterial florafor the treatment of intestinal inflammationsinflammatory bowel diseases and inflammations of the lower gastrointestinal tractfor the treatment of ulcerative colitis and crohn's disease in which inflammation is present both in the small intestine and in the colon; pharmaceutical products containing micro-organisms cultureslactic acid bacteria and bifidobacteria having probiotic activity on humans for the treatment of diseasesintestinal disordersdiarrhea and to re-equilibrate the intestinal bacterial florafor the treatment of intestinal inflammationsinflammatory bowel diseases and inflammations of the lower gastrointestinal tractfor the treatment of ulcerative colitis and crohn's disease in which inflammation is present both in the small intestine and in the colon; pharmaceutical productsprobiotic lactic acid bacteriaprobiotic bifidobacteria which are able to ferment and use the fibres in the human organism for the treatment of diseasesintestinal disordersdiarrhea and to re-equilibrate the intestinal bacterial florafor the treatment of intestinal inflammationsinflammatory bowel diseases and inflammations of the lower gastrointestinal tractfor the treatment of ulcerative colitis and crohn's disease in which inflammation is present both in the small intestine and in the colondietary and nutritional supplements containing microorganisms and cultures of microorganismsprobiotic lactic acid bacteriaprobiotic bifidobacteria which are able to ferment and use the fibres in the human organism; pharmaceutical products for oral consumptioncapsulestabletssolutionssuspensionsgranulespellets in dried formcontaining micro-organisms cultureslactic acid bacteria and bifidobacteria having probiotic activity on humans for the treatment of diseasesintestinal disordersdiarrhea and to re-equilibrate the intestinal bacterial florafor the treatment of intestinal inflammationsinflammatory bowel diseases and inflammations of the lower gastrointestinal tractfor the treatment of ulcerative colitis and crohn's disease in which inflammation is present both in the small intestine and in the colondietary and nutritional supplements for oral consumptioncapsulestabletssolutionssuspensionsgranulespellets in dried formcontaining micro-organisms cultureslactic acid bacteria and bifidobacteria having probiotic activity on humans; microbial and biological preparations for medical use for improving the physical well-being of humansreducing inflammation and pain; dietary supplements for medical usebaby foodall the above containing preparations and products resulting from the processing of microorganismsparticularly metabolites obtained from the processing of probiotic bacterial cultures; probiotic and nutritional and dietary supplements; antifungal preparations; antifungal creams for medical use; vaginal antifungal preparations; fungal and bacterial probiotic supplementsnutritional supplement for digestive health; nutritional supplement for combating digestive disorders such as Crohn's Diseaseulcerative colitis and irritable bowel syndrome; beverages containing probiotic compositions for use as a nutritional supplement; food supplements containing probiotic compositions; human food supplements products containing probiotic compositions; animal food products containing probiotic compositionsprobiotic animal feed; dietary supplement drink mixesprobiotic compositions in the form of mixes to added to beverages; dietary supplements in the nature of probiotic compositions for mixing with cereal

Publications

History of USPTO decisions and trademark events.

53 publications found

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

10/21/2025

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

10/21/2025

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

10/21/2025

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

02/15/2023

R.PR

REGISTERED-PRINCIPAL REGISTER

04/19/2022

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

03/15/2022

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

03/13/2022

SUPC

STATEMENT OF USE PROCESSING COMPLETE

03/01/2022

IUAF

USE AMENDMENT FILED

02/18/2022

EISU

TEAS STATEMENT OF USE RECEIVED

02/18/2022

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

08/10/2021

EX5G

SOU EXTENSION 5 GRANTED

08/09/2021

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

08/06/2021

EXT5

SOU EXTENSION 5 FILED

07/28/2021

EEXT

SOU TEAS EXTENSION RECEIVED

07/28/2021

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

02/17/2021

EX4G

SOU EXTENSION 4 GRANTED

02/15/2021

EXT4

SOU EXTENSION 4 FILED

02/15/2021

EEXT

SOU TEAS EXTENSION RECEIVED

02/15/2021

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

10/05/2020

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

10/05/2020

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

10/05/2020

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

10/05/2020

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

10/05/2020

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

08/21/2020

EX3G

SOU EXTENSION 3 GRANTED

08/19/2020

EXT3

SOU EXTENSION 3 FILED

08/19/2020

EEXT

SOU TEAS EXTENSION RECEIVED

08/19/2020

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

02/28/2020

EX2G

SOU EXTENSION 2 GRANTED

02/27/2020

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

02/27/2020

EXT2

SOU EXTENSION 2 FILED

02/18/2020

EEXT

SOU TEAS EXTENSION RECEIVED

02/18/2020

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

02/18/2020

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

08/20/2019

EX1G

SOU EXTENSION 1 GRANTED

08/16/2019

EXT1

SOU EXTENSION 1 FILED

08/16/2019

EEXT

SOU TEAS EXTENSION RECEIVED

08/16/2019

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

02/19/2019

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

01/30/2019

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

12/25/2018

PUBO

PUBLISHED FOR OPPOSITION

12/25/2018

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

12/05/2018

ALIE

ASSIGNED TO LIE

11/12/2018

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

10/28/2018

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

10/26/2018

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

10/26/2018

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

10/26/2018

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

04/30/2018

GNRT

NON-FINAL ACTION E-MAILED

04/30/2018

CNRT

NON-FINAL ACTION WRITTEN

04/30/2018

DOCK

ASSIGNED TO EXAMINER

04/26/2018

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

01/29/2018

Continuous trademark protection

Get notified about every new filing that threatens POWERED BY BIOHM or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.